Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Department of Health and Human Services took steps this week to speed the development and manufacturing of vaccines to prevent COVID-19, working with New Jersey-based …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the closing of the previously announced public offering, reflective of …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has commenced an underwritten public offering of its common …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that the Company has completed enrollment in its 14-week …
Read More
BERWYN, PA — Complexa Inc. announced the appointment of Elisabeth Leiderman, MD, MBA, as Chief Business Officer. Dr. Leiderman formerly served as Senior Vice President, Head of Corporate Development for …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that it has successfully achieved its patient screening target …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. …
Read More
CHEYNEY, PA — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announced the opening of its R&D operations at the Cheyney University science center …
Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a specialty pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, this week announced the presentation of positive data from a …
Read More